3M Launches Production-Scale Sizes of its Upstream Purifiers

The biological reagents provider is moving to a 5000-square-foot site in Cambridge Technopark to accommodate the company’s growth.

Northway Biotech will develop and scale production of AATec’s ATL-105 for the treatment of non-CF bronchiectasis.

The consortium will focus on the delivery of a fully automated robotics cell and gene therapy manufacturing platform.

As development of novel drugs accelerates, enhanced downstream production processes maintain product efficacy, safety, and quality.

The Purolite AP+50 affinity chromatography resin has a 50-micron bead size that offers dynamic binding capacity of the AP resin platform while providing durability for monoclonal antibody capture.

A continuous biomanufacturing platform can process higher/lower quantities of a drug as needed and allow manufacturers to respond to changing markets.